The Brain+ Blog

Below you can find information about scientific discoveries, articles about our lifestyles influence on brain health and general insights into brain training and the opportunities it presents.

24. March 2023

Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine

Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine A key finding from the recently released 2nd systematic Cochrane review (Woods et al., 2023) is the confirmation that medication combined with CST results […]

20. March 2023

First sales contract expanded

Brain+ expands its first sales contract close to doubling it In December 2023 Brain+ closed its first sales contract with Herning Municipality, and Herning has chosen to expand that contract, nearly doubling the contractual size. […]

14. March 2023


Respected dementia experts and Brain+ get EU grant to research how to optimize digital at-home treatments for people with dementia The EU Joint Programme – Neurodegenerative Disease Research has granted 496,000SEK (or 48,405 euros) to […]

2. March 2023

New Cochrane review confirms CST

New Cochrane review confirms the benefit and relevance of Cognitive Stimulation Therapy (CST) for people with dementia A 2nd systematic Cochrane review, ‘Cognitive stimulation to improve cognitive functioning in people with dementia’ (Woods et al., 2023), […]

21. February 2023


Brain+ showcases its digital dementia products At the Danish-Japanese Welfare and Health Tech Business Conference Brain+ is part of a group of Danish welfare and health tech companies that have been invited to present their […]

8. February 2023


Successful conclusion of EU project Alzheimer’s Detect & Prevent  with early validation of two Brain+ DTx technologies and extra funding  The information communicated in this announcement is “inside information” for the purposes of article 7 of […]

26. January 2023

Brain+ completes Swedish research version of its dementia product

Brain+ completes Swedish research version of its dementia product with the Research Institutes of Sweden and extends the collaboration A strong Swedish partner research network Brain+ has over the last three years entered multiple Alzheimer’s […]

11. January 2023

Clinical Study results promising for CCT product

Results from a clinical study provide promising feasibility indications for Brain+’ CCT technology for cognitive training A study conducted by Nottingham University as part of the Brain+ led European Horizon2020 project called Alzheimer’s Detect & […]

2. January 2023

Brain+ first municipal sale of its new dementia product

Brain+ closes 2022 with the first municipal sale of its new dementia product and begins the monetization journey Another milestone has been met by Brain+ as it closes the year with the first sale of […]

29. December 2022

3-Year Innovation Project is Completed

3-year innovation project with the Danish Life Science Cluster is completed with the Brain+ CST-Therapist Companion product as the final output A 3-year collaboration project between VIA University College, MedTech Innovation Consortium (MTIC), and Brain+ […]

22. December 2022

Strong Q4 with Product Launch & Successful Capital Raise

Brain+ announces Investor Webinar  following strong Q4 with product launch and succesful capital raise Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful […]

16. December 2022

Pilot with volunteers from DaneAge Association

Brain+ begins commercial pilot with volunteers from the DaneAge Association Brain+, a pioneer in the development of digital therapeutics for Alzheimer’s disease, is excited to announce the launch of a pilot project with DaneAge (Ældre Sagen) […]

14. December 2022

Implementation of an ISO 13485 for Medical Devices

Brain+ completes the implementation of an ISO 13485 Quality Management System for Medical Devices Brain+ has successfully completed the implementation of an ISO 13485-compliant Quality Management System (QMS). Such a system helps to set standards […]

9. December 2022

WHO points to CST to solve the dementia burden

A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia […]

27. October 2022

Leading dementia researcher joins Brain+

Brain+ adds new clinical and development competences To accelerate and support market access of its digital dementia product portfolio Rising star clinical dementia researcher to join the company in a new position as Clinical Director […]

24. October 2022

CST Therapist Companion advancing

Brain+ further advances its first digital dementia product, Cognitive Stimulation Therapy (CST) – Therapist Companion Commercial launch in Denmark will be November 1, 2022 Adaptation of a UK product version for the United Kingdom starts […]

19. October 2022

Brain+ begins early activity and brand building in the US

Brain+ begins early activity and brand building in the US The United States (US) is a key future market for Brain+, and early brand building and exploration is now ongoing Brain+ has been selected and […]

12. October 2022

First milestone met

Brain+ meets milestone with Rox Health (Roche Germany) Rox Health has approved the German version of Brain+’s first digital dementia product, CST-Therapist Companion, for commercial launch.  Meeting this milestone unlocks access for Brain+ to additional […]

11. October 2022

New Research report values Brain+

New research report values Brain+ at DKK 4.1 per share in the base case, and DKK 6.4 in the bull case. The research report concludes that “Brain+ is in a strong position to grow towards […]

28. September 2022

Accelerated launch Q2 2023

  Brain+ partners with German medical distributor Advances launch of its first CST dementia product in Germany to Q2 2023   Through Coopmed, Brain+ will be represented by experienced and local medical sales managers in […]